NFκB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53

Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts

(2012) Giorgio Trinchieri   Annual Review of Immunology

Genome-wide analysis of STAT3 binding in vivo predicts effectors of the anti-inflammatory response in macrophages

(2012) A. P. Hutchins et al.   BLOOD

Emerging avenues linking inflammation and cancer

(2012) Joydeb Kumar Kundu et al.   FREE RADICAL BIOLOGY AND MEDICINE

NF-κB and the link between inflammation and cancer

(2012) Joseph A. DiDonato et al.   IMMUNOLOGICAL REVIEWS

A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line

(2012) Inès Souissi et al.   Molecular Cancer

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

JAK/STAT Pathway Plays a Critical Role in the Proinflammatory Gene Expression and Apoptosis of RAW264.7 Cells Induced by Trichothecenes as DON and T-2 Toxin

(2012) Xu Wang et al.   TOXICOLOGICAL SCIENCES

FAT10 modifies p53 and upregulates its transcriptional activity

(2011) Tianwei Li et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

The Unholy Trinity: Inflammation, Cytokines, and STAT3 Shape The Cancer Microenvironment

(2011) Ning Li et al.   CANCER CELL

A Requirement of STAT3 DNA Binding Precludes Th-1 Immunostimulatory Gene Expression by NF- B in Tumors

(2011) H. Lee et al.   CANCER RESEARCH

The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity

(2011) S H Seo et al.   GENE THERAPY

Tumor Promotion via Injury- and Death-Induced Inflammation

(2011) Ali Kuraishy et al.   IMMUNITY

FAT10 mediates the effect of TNF-  in inducing chromosomal instability

(2011) J. Ren et al.   JOURNAL OF CELL SCIENCE

STAT3 Negatively Regulates Type I IFN-Mediated Antiviral Response

(2011) W.-B. Wang et al.   JOURNAL OF IMMUNOLOGY

Crosstalk in NF-κB signaling pathways

(2011) Andrea Oeckinghaus et al.   NATURE IMMUNOLOGY

Immunity, Inflammation, and Cancer

(2010) Sergei I. Grivennikov et al.   CELL

Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells

(2010) Yan Liu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Expression of a Homeostatic Regulator, Wip1 (Wild-type p53-induced Phosphatase), Is Temporally Induced by c-Jun and p53 in Response to UV Irradiation

(2010) Ji-young Song et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells

(2010) Lesley A Mathews et al.   Molecular Cancer

Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors

(2009) Heehyoung Lee et al.   CANCER CELL

Inflammation and oncogenesis: a vicious connection

(2009) Sergei I Grivennikov et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer

(2009) Sergei I. Grivennikov et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases

(2009) Xiaoyu Hu et al.   IMMUNITY

The Ubiquitin-Like Protein FAT10 Mediates NF- B Activation

(2009) P. Gong et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Chemical Probes that Competitively and Selectively Inhibit Stat3 Activation

(2009) Xuejun Xu et al.   PLoS One

Prediction and Experimental Validation of Novel STAT3 Target Genes in Human Cancer Cells

(2009) Young Min Oh et al.   PLoS One

FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging

(2009) Feng Ji et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon

(2008) S Lukasiak et al.   ONCOGENE